Document is current

Article History

Received: 17 October 2024

Accepted: 3 March 2025

First Online: 12 March 2025

Declarations

:

: TM and JT are employees of The Health Policy Partnership, a consultancy which has several clients in the life sciences industry, and which received support for this study from AstraZeneca and Sanofi. KA has received funding from Sanofi for conference attendance. MF is Chief Medical Officer of The Association of Immunization Managers (AIM), which receives support in the form of educational grants from Sanofi Pasteur, Merck, Glaxo Smith Kline, Sequirus, AstraZeneca, Novavax, Bavarian Nordic and Dynavax. These corporations do not provide input into AIM policies or procedures and AIM does not endorse specific brands, products or companies. JH has received advisory board fees from Sequirus US and Sanofi. JPM has received advisory board and speaker fees and conference attendance funding from AstraZeneca and Sanofi. MSL has received advisory board and lectureship fees from AstraZeneca and a travel grant from Sanofi. CWO has received travel grants and speaker fees from AstraZeneca, MSD, Novavax, Pfizer, Sanofi and Sequirus. JAA has collaborated in educational activities funded by AstraZeneca, GlaxoSmithKline, MSD, Pfizer, Sanofi and Seqirus, as a researcher in clinical trials for GlaxoSmithKline and Sanofi and as a consultant for AstraZeneca, GlaxoSmithKline, MSD, Pfizer and Sanofi advisory boards.